文献速递生殖医学

连续IVF周期获卵数及卵巢反应类别的患者内变异

Intrapatient variability in the number of retrieved oocytes and ovarian response categories between consecutive in vitro fertilization cycles.
PubMed 文献 · Fertil Steril · 2026-03-17

这项跨大陆多中心回顾性队列研究分析了801对采用相同卵巢刺激方案的连续IVF周期,发现获卵数平均变化62.7%,中位变化40%,47.57%的患者卵巢反应类别发生偏移,各年龄段均存在周期间波动。

要点

  • 相同刺激方案下获卵数平均变化62.7%,中位变化40%
  • 47.57%患者卵巢反应类别偏移,7.61%跨两级偏移
  • ≥40岁女性获卵数中位变化44.4%,高于≤30岁的33.3%

核心结论

  • 即使卵巢刺激方案相同,获卵数仍存在周期间波动,各年龄段均如此,提示卵泡准备度和反应存在波动。
  • 基于获卵数的卵巢反应分类受到挑战,强调IVF卵巢刺激周期关键绩效指标的重要性。

研究设计与样本

  • 跨大陆、多中心回顾性队列研究,纳入2014-2024年接受IVF卵巢刺激、6个月内至少2个周期且方案、促性腺激素类型及初始和每日剂量相同、均行全胚冷冻且每周期至少获1枚卵子的患者。
  • 分析每例患者最早符合标准的连续两周期,共801对周期满足标准。

主要发现

  • 总体获卵数平均变化百分比为62.7%,第25、50(中位)、75百分位分别为16.7%、40%、80%。
  • 50%患者获卵数差异>33%,381/801(47.57%)患者卵巢反应类别发生偏移,其中29/381(7.61%)跨两个类别偏移。
  • ≥40岁女性获卵数中位变化44.4%,≤30岁为33.3%。
  • 每个周期获卵数与患者两周期平均获卵数的决定系数R²=0.834。
  • 成熟卵母细胞获卵数平均变化百分比为74.5%,中位为50%。

关键数值与推荐

  • 卵巢反应类别定义:低反应1-3枚卵子,次优反应4-9枚,正常反应10-14枚,高反应≥15枚。
  • 平均每日促性腺激素剂量为361.5±112.6 IU。

临床怎么用

  • 临床咨询时应告知患者即使方案相同,获卵数也可能出现较大波动。
  • 不宜仅凭单周期获卵数对患者卵巢反应进行固定分类。
  • 应关注IVF卵巢刺激周期的关键绩效指标以评估周期质量。

局限性

  • 回顾性研究设计。
  • 仅纳入全胚冷冻且每周期至少获1枚卵子的患者,可能存在选择偏倚。
  • 仅分析符合特定条件的连续两周期,未涵盖所有IVF人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine intrapatient variability in retrieved oocyte numbers across consecutive in vitro fertilization (IVF) ovarian stimulation (OS) cycles with an identical OS protocol. DESIGN: Cross-continental, multicenter retrospective cohort study. SUBJECTS: Patients undergoing OS for IVF (2014-2024) with ≥2 OS cycles within 6 months using the same OS protocol, gonadotropin type, and initial and daily dose; all underwent freeze-all-cycles and had ≥1 oocyte retrieved in each of the two consecutive cycles. For each patient, the earliest consecutive pair meeting criteria was analyzed. EXPOSURE: Oocyte yield in the first vs. consecutive OS cycle. MAIN OUTCOME MEASURES: Primary outcomes included: (i) average percentage change in oocyte yield between cycles (higher divided by lower oocyte yield); and (ii) 25th, 50th (median), and 75th percentiles of oocyte-yield percentage change, overall and by age groups (≤30, 31-35, 36-39, ≥40 years). Secondary outcomes included: (i) coefficient of determination (R2) between each cycle's oocyte count and the patient's average oocyte count across both cycles, representing the extent of variation explained by the patient's baseline profile; (ii) shifts between ovarian response categories, poor (1-3 oocytes), suboptimal (4-9), normal (10-14), and hyper-response (≥15); (iii) average and median percentage change in mature-oocyte yield. RESULTS: Overall, 801 cycle pairs met the inclusion criteria. Mean daily gonadotropin dosage was 361.5 ± 112.6 IU; with comparable demographic and cycle characteristics between cycles. Overall, the average percentage change in oocyte yield was 62.7%; the 25th, 50th (median), and 75th percentiles were 16.7%, 40%, and 80%, respectively. Fifty-percent of patients showed >33% difference in retrieved oocytes, and 381/801 (47.57%) shifted ovarian response categories, with 29/381 (7.61%) shifting across two categories. Median oocyte yield percentage change was 44.4% in women ≥40 vs. 33.3% in those ≤30 years. The coefficient of determination between each cycle and the average of the two cycles was 0.834, representing the optimal performance any prediction model could achieve when predicting oocyte yield given baseline characteristics alone. The average percentage change in mature oocyte yield was 74.5%, with a median of 50%. CONCLUSION: Cycle-to-cycle variations in retrieved oocyte yield exist despite the same cycle conditions, across all age groups, reflecting fluctuations in ovarian follicular readiness and response, challenging ovarian response categorization based on oocyte yield and stressing the importance of key performance indicators in IVF OS cycles.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Hochberg A, Reuvenny S, Itzhak N, et al. Intrapatient variability in the number of retrieved oocytes and ovarian response categories between consecutive in vitro fertilization cycles. Fertil Steril. 2026. PMID: 41856348. doi:10.1016/j.fertnstert.2026.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。